Choose the GLP-1 path
you want to explore.
Tap a route, compare formats, and move into a short quiz that turns curiosity into clinical clarity before any provider review.
Treatments are evaluated case by case. Not all patients qualify and results vary.
Interactive hero
Explore before the quiz
With the visual trust of NoGuilt
Weekly route
Compounded semaglutide
What you're seeing
One of the most recognized GLP-1 pathways. Ideal for patients who want to begin with the weekly route they hear about most often.
What matters most
Next step
Take the quiz and find your strongest starting point.
The quiz gives a provider the context needed to review your case and decide whether it makes sense to move forward.
Brand references are educational only. Eligibility still depends on evaluation and licensed provider review.
Open guided quizMove the slider.
Compare your likely range.
Based on clinical trial averages. It does not predict your result or guarantee access to treatment.
Quick picks
Guidance reference
172lbs
Change range
-48 lbs
22% body weight
Guidance comparison at 12 months:
Diet only
~5% historical average
Semaglutide
~15% clinical average
Tirzepatide
~22% clinical average
Reference data from STEP and SURMOUNT trials. Individual results vary and approval depends on medical review.
Continue to evaluationCompare compounded, oral, and FDA references with clarity before you choose.
Review formats, brands, and known routes so you enter evaluation with more context and fewer doubts.
Main routes
The compounded options patients ask about first.
Semaglutide and tirzepatide usually anchor the first serious comparison before someone moves into the evaluation.
Important
The final route still depends on clinical review, history, goals, and availability.
Does your case need a
provider review?
3 short questions · about 1 minute
Which range is closest to your goal?
This helps frame the review. Final approval always depends on the provider.
Choose the route you want reviewed
Tap an option to see the detail. The final decision always depends on a licensed provider.
Selected route
Tirzepatida
Dual-action option with medical review and ongoing follow-up.
For patients who want a more intensive comparison from the start.
- Full evaluation
- Dual GLP-1 + GIP action
- Personalized plan
Before you continue
Useful when you want to compare a stronger dual-action route before moving forward.
Subject to clinical review and eligibility.
Go to evaluationPrices correspond to plan options subject to evaluation and approval by an independent licensed provider. Plans vary based on your history and eligibility.